Nanjing Hanxin Pharmaceutical Technology Co. Ltd., Building C5, No. 9, Weidi Road Xianlin University Town Nanjing Shi Jiangsu Sheng , 210046 China, (b)(4)FEI 3015142388Issued Nov 3, 2026Center for Drug Evaluation and Research (CDER)
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3015142388.
Violations4
Issue DateNov 3, 2026
Product TypeDrugs
StatusOpen
Letter Details
Firm
Nanjing Hanxin Pharmaceutical Technology Co. Ltd.
Location
Nanjing Hanxin Pharmaceutical Technology Co. Ltd., Building C5, No. 9, Weidi Road Xianlin University Town Nanjing Shi Jiangsu Sheng , 210046 China, (b)(4)
FEI Number
3015142388
Country
China
Issue Date
November 03, 2026
Issuing Office
Center for Drug Evaluation and Research (CDER)
Product Type
Drugs
Status
Open
Subject
Request for Records/CGMP/API/Adulterated
Nanjing Hanxin Pharmaceutical Technology Co. Ltd. FDA Warning Letter, November 3, 2026
Talk to a Specialist